Corden Pharma Announces €900M Investment in GLP-1 Peptide Platform Expansion
Corden Pharma has announced its largest strategic investment to date with a committed spend of approximately €900 million over the next three years to grow…
Corden Pharma has announced its largest strategic investment to date with a committed spend of approximately €900 million over the next three years to grow…
CordenPharma, a global CDMO specialising in the manufacture of Drug Substances (APIs) for complex modalities, and Certest, a Spanish company focused on developing new products…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.